P3 Health Partners
PIII
62 hedge funds and large institutions have $19.6M invested in P3 Health Partners in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 22 reducing their positions, and 11 closing their positions.
2.35% less ownership
Funds ownership: 18.86% → 16.52% (-2.3%)
6% less funds holding
Funds holding: 66 → 62 (-4)
32% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 22
36% less capital invested
Capital invested by funds: $30.6M → $19.6M (-$11M)
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$2.31M |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$330K |
| 3 |
Walleye Capital
New York
|
+$93.1K |
| 4 |
Lido Advisors
Los Angeles,
California
|
+$83.3K |
| 5 |
WCP
Welch Capital Partners
Harrison,
New York
|
+$78.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.76M |
| 2 |
Janus Henderson Group
London,
|
-$1.85M |
| 3 |
Millennium Management
New York
|
-$459K |
| 4 |
HF
HRT Financial
New York
|
-$436K |
| 5 |
Nuveen
Charlotte,
North Carolina
|
-$241K |
PIII Hedge Fund Activity: Q1 2024 in Review
62 of the 6,961 institutional investors tracked by Wall St. Rank reported a position in P3 Health Partners (PIII) for Q1 2024, worth a combined $19.6M — down 36% from $30.6M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of PIII and 7 opened new positions — a net loss of 4 holders — while 22 trimmed existing stakes and 15 added.
The largest buyer was Ameriprise, adding an estimated $2.31M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $2.76M sold.
- 62 institutional investors held P3 Health Partners (PIII) as of Q1 2024, down from 66 in Q4 2023.
- Funds reported $19.6M of P3 Health Partners stock for Q1 2024, down 36% quarter-over-quarter.
- 7 funds opened new P3 Health Partners positions in Q1 2024 and 11 closed out, a net change of -4 holders.
- The largest P3 Health Partners buyer in Q1 2024 was Ameriprise, an estimated $2.31M added.
- The largest P3 Health Partners seller in Q1 2024 was Alyeska Investment Group, an estimated $2.76M sold.
Based on aggregated 13F filings for Q1 2024.